Is there a ribosomal weakness in cancer?
Once thought too conserved to be a therapeutic target for cancer, new insights could reveal ribosomal biogenesis to be an Achilles heel. Faraz K. Mardakheh gives us a breakdown… Ribosomes […]
Once thought too conserved to be a therapeutic target for cancer, new insights could reveal ribosomal biogenesis to be an Achilles heel. Faraz K. Mardakheh gives us a breakdown… Ribosomes […]
Backed by £5.5m of funding from CRUK and its partners, the hugely ambitious CRC-STARS programme aims to revolutionise how bowel cancer is treated. Much has been written about the dawn […]
Join us this October for the 2025 Crick International Cancer Conference! We have an exciting line-up of speakers highlighting the most recent advances in cancer biology. Major themes include: We aim […]
The mysteries of the epiregulome need to be tackled head-on if we are to get new precision treatments for blood cancers says Lisa Russell. Here she takes us through the […]
This online seminar will focus on the role of the periphery and non-neuronal cells in Parkinson’s pathogenesis, offering key insights and an opportunity for further discussion. The seminar will be […]
A few years into the generative AI revolution, Andrew Porter looks at where we are now with these new tools, and what researchers need to think about before diving in… As […]